Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 153 results found. Search for [ Adar Poonawalla coronavirus vaccine ]

Results 80 to 100 of 153
BusinessToday.In
September 12, 2020
DCGI VG Somani in his order also asked Serum Institute to suspend any new recruitment in Phase 2 and 3 clinical trials until further notice; SII also need to increase safety monitoring of test subjects vaccinated under trials so far


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


Rajeev Dubey & Manoj Sharma
September 10, 2020
Phase 2/3 COVID-19 vaccine trials being conducted across 17 sites in India paused till further instructions from regulator; could delay vaccine development process as Serum Institute is front-runner when it comes to companies producing COVID-19 vaccines in India


BusinessToday.In
New Delhi, September 9, 2020
British-Swedish bio-pharmaceutical firm AstraZeneca PLC, working with a team of the University of Oxford, has temporarily paused the clinical trial of its coronavirus vaccine in the UK after one of the volunteers developed an 'unexplained' illness. Serum Institute CEO, Adar Poonawalla, referred to the issue as unrelated and said that it would not impact the vaccine trials in India. Watch the video for more.Also Read: AstraZeneca pauses COVID-19 trials: In which countries are the trials taking place?


BusinessToday.In
September 9, 2020
AstraZeneca vaccine trials halted: Dr. Angela Rasmussen, virologist at Columbia University said that this is exactly why Phase 3 of clinical trials are so important. She added that this might not be a big deal


Manali
September 9, 2020
The initial symptoms of Transverse myelitis include pain in the lower back or sharp, shooting sensations that radiate down the arms, legs, or around the torso


Rajeev Dubey
New Delhi, September 9, 2020
Serum Institute CEO, Adar Poonawalla, told BusinessToday that the Indian trials, which were being conducted on the Oxford vaccine, had not been stopped yet. AstraZeneca PLC, which is working with a team of the University of Oxford, on Wednesday decided to temporarily pause the clinical trial of its coronavirus vaccine after one of the volunteers in the UK developed an 'unexplained' illness. Watch the video for more.Also Read: India coronavirus vaccine trials 'not stopped yet': Serum's Adar Poonawalla after AstraZeneca halts global trials


PB Jayakumar
September 9, 2020
Serum has also started manufacturing the vaccine, targeting to use in India and 92 other countries upon completion of trials and regulatory clearances


BusinessToday.In
September 9, 2020
The late-stage phase 3 clinical trial of AstraZeneca's COVID-19 vaccine is being conducted at various sites, including the United Kingdom, where the adverse event was reported


Rajeev Dubey & Manoj Sharma
September 9, 2020
\"AstraZeneca has paused the trials due to some unrelated issue with a patient in the UK, and we'll have to wait for AstraZeneca to explain what happened but this is not vaccine-related,\" says Poonawalla


BusinessToday.In
September 9, 2020
AstraZeneca said that an adverse reaction was observed in one of the volunteers in the UK. According to the pharmaceutical firm, the nature of the adverse reaction remained unknown, though the participant is expected to recover


BusinessToday.In
New Delhi, September 9, 2020
Goldman Sachs expects India's economy to rebound by 2021Global rating agency Goldman Sachs has cut its estimates for growth in India's gross domestic product (GDP) for the current fiscal 2020-21 (FY21), but it expects the economy of the country to see a full-bound recovery by 2021. The research firm expects real GDP growth to contract 14.8 per cent in FY21 against its earlier estimate of 11.8 per cent contraction in this period. The agency, however, expects real GDP to bounce back strongly t...


Associated Press
September 9, 2020
Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain


Niti Kiran
September 8, 2020
Consumption of coal by end-user industries also improved marginally from 54.2 MT in May to 56.7 MT in June 2020, though, on a year-on-year basis consumption of coal in June was lower by 19.8 per cent


BusinessToday.In
September 8, 2020
The announcement of Russian COVID-19 vaccine Sputnik V and developments in the Sushant Singh Rajput death case were major news stories for the month of August


BusinessToday.In
September 8, 2020
Adar Poonawalla's Serum Institute of India had signed a deal with British-Swedish pharma company AstraZeneca to manufacture the potential vaccine developed by the Jenner Institute of Oxford University


BusinessToday.In
September 3, 2020
The 2020 Fortune 40 under 40 list highlights 40 influential people each in five categories of technology, healthcare, finance, media and entertainment, and government and politics from across the world


Reuters
August 28, 2020
The company said it would have nine operating units that would sit under four geographical segments, along with global ventures and bottling investments divisions, compared with its current model that includes 17 business units


Reuters
August 28, 2020
China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), also said it had obtained emergency use approval for a coronavirus vaccine candidate


BusinessToday.In
August 28, 2020
Coronavirus vaccine: The market for coronavirus vaccine in India could potentially be $6 billion in terms of sales for the coming three years


PAGES 5 OF 8  12345